Knowledge Gaps in Vaccination Against Meningococcal Disease

Meningococcal disease is a rare but aggressive bacterial infection that can be fatal or cause serious life-long disability within 24 hours of onset of symptoms: about 10-15 percent of people infected with meningococcal disease will die, and 11-19 percent of survivors will have long-term consequences, including deafness, nervous system problems, brain damage or loss of limbs.

GSK is hosting an event (#GSKsummit) on December 9, 2015 in New York City with bloggers, advocates, a patient survivor and caregiver to brainstorm ways to reach parents and young people with important disease information and to highlight knowledge gaps as identified in two national consumer polls with parents and teens/young adults. Follow #GSKSummit on Twitter to learn more.

For more information about the event, please contact: